Catalyst Pharmaceuticals Inc (CPRX)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 422,889 | 313,672 | 179,810 | 118,949 | 102,034 |
| Revenue | US$ in thousands | 491,734 | 398,204 | 214,203 | 140,833 | 119,073 |
| Gross profit margin | 86.00% | 78.77% | 83.94% | 84.46% | 85.69% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $422,889K ÷ $491,734K
= 86.00%
Based on the provided data, Catalyst Pharmaceuticals Inc's gross profit margin has shown a downward trend over the years. It was 85.69% as of December 31, 2020, decreased to 84.46% by December 31, 2021, and further declined to 83.94% by December 31, 2022.
The gross profit margin saw a more significant decrease to 78.77% by December 31, 2023, before experiencing a slight recovery to 86.00% by December 31, 2024. This fluctuation in the gross profit margin may indicate changes in the company's cost structure, pricing strategies, or sales mix over the years.
Overall, the declining trend in gross profit margin from 2020 to 2023 followed by a recovery in 2024 suggests that Catalyst Pharmaceuticals Inc may have faced challenges in maintaining profitability, but the improvement in 2024 may indicate management efforts to address these issues. It is essential for the company to continue monitoring and managing its cost of goods sold to ensure sustainable profitability in the future.
Peer comparison
Dec 31, 2024